Infections in children with diabetes mellitus by Vidya Krishna, -
Dissertation on 
 
INFECTIONS IN CHILDREN WITH 
DIABETES MELLITUS  
 
Submitted to 
The Tamilnadu Dr.M.G.R. Medical University 
in partial fulfillment of the requirement  
for the award of degree of 
 
MD BRANCH VII 
PAEDIATRIC MEDICINE 
 
INSTITUTE OF CHILD HEALTH  
AND HOSPITAL FOR CHILDREN 
MADRAS MEDICAL COLLEGE  
CHENNAI 
 
 
 
THE TAMILNADU DR. M.G.R. MEDICAL UNIVERSITY 
CHENNAI, TAMILNADU 
 
MARCH 2007 
 
CERTIFICATE 
 
 Certified that this dissertation entitled “INFECTIONS IN CHILDREN WITH 
DIABETES MELLITUS” is a bonafide work done by Dr. VIDYA KRISHNA, Post Graduate, 
Department of Paediatric Medicine, Institute of Child Health and Hospital for Children, Madras 
Medical College, Chennai during the academic year 2004-2007. 
 
 
 
 
Prof. SARADHA SURESH, M.D., Ph.D., 
Addl. Professor of Paediatrics, 
Institute of Child Health and Hospital for 
Children, 
Madras Medical College, 
Chennai. 
Prof. R. KULANDAI KASTHURI, M.D., D.C.H., 
Director and Superintendent (I/C), 
Institute of Child Health and Hospital for 
Children, 
Madras Medical College, 
Chennai. 
 
 
 
 
 
 
 
 
 
Prof. KALAVATHI PONNIRAIVAN, B.Sc., M.D., 
Dean, 
Madras Medical College, 
Chennai. 
 
 
 
ACKNOWLEDGEMENT 
 
 I express my sincere thanks to Prof. Dr. KALAVATHI PONNIRAIVAN, B.Sc., M.D., 
Dean, Madras Medical College for allowing me to conduct the study using the available 
facilities.  
 I whole-heartedly thank Prof. Dr. R. KULANDAI KASTHURI, M.D., D.C.H., Director 
and Superintendent (I/C), Institute of Child Health and Hospital for Children for her invaluable 
help and guidance.  
 I feel greatly indebted to Prof. Dr. SARADHA SURESH, M.D., Ph.D., Addl. Professor of 
Paediatrics, Institute of Child Health and Hospital for Children, for her help and guidance.  
 I also thank our former Director and Superintendent  
Prof. MANGAYARKARASI SENGUTTUVAN, for her guidance in doing this study. 
        I thank Dr. D. GUNASINGH, Dr. C. SUBBULAKSHMI, Dr. LUKE RAVI 
CHELLIAH and Dr. V. POOVAZHAGI for their comments and suggestions in this study. 
 I am indebted to all the children with diabetes mellitus and their parents without whom 
this study would not have been possible. 
 Lastly I want to express my gratitude to my mother, who has been the source of constant 
encouragement and love and affection throughout my life and career.  
 
 
 
 CONTENTS 
 
SL.NO. TITLE PAGE NO. 
1. INTRODUCTION 1 
2. IMMUNOPATHOLOGY OF INFECTIONS IN 
DIABETES MELLITUS  
5 
3. LITERATURE REVIEW  18 
4. STUDY JUSTIFICATION  27 
5. OBJECTIVES OF THE STUDY 28 
6. STUDY METHODOLOGY 29 
7. RESULTS  37 
8. SUMMARY  OF THE STUDY 63 
9. DISCUSSION 65 
10. CONCLUSION 69 
11. ANNEXURE – I   DATA COLLECTION FORMS  
12. ANNEXURE – II   BIBLIOGRAPHY   
  
 
  
 
 
 
 
 
 
 
 
 
 
Introduction 
 
 
1. INTRODUCTION 
 Diabetes mellitus comprises of a group of common metabolic disorders that 
share the phenotype of hyperglycemia. It is the most common endocrine – 
metabolic disorder affecting both children and adults. The worldwide prevalence of 
type 1 and type 2 diabetes mellitus is increasing worldwide, with especially type 2 
diabetes mellitus rising more rapidly both in children and adults due to the recent 
epidemic of obesity and also due to lifestyle changes. In 2000, the prevalence of 
diabetes mellitus was estimated to be 0.19% in people <20years and 8.6% in 
people >20 years1. 
 Type 1 diabetes mellitus, the most common form of diabetes mellitus 
encountered in childhood, accounts for approximately two thirds of all cases of 
diabetes mellitus in children2. Incidence of the disease varies from as high as 50 
per 100,000 population in European countries like Finland to as low as 0.1 per 
100,000 population in Asian countries like India2. The incidence of the disease is 
increasing especially in countries with a previous low incidence of autoimmune 
diseases3. It is predicted that the overall incidence of type 1 diabetes will be 40% 
higher in 2010 than in 19973. 
 
 
 
 
Magnitude of the problem in India: 
 Though this disease has a low incidence in our country of only 0.1 per 
100,000 population the magnitude of the problem is indeed huge considering the 
chronicity of the illness, its effect on growth and development and long-term 
complications on the various organ systems causing considerable morbidity and 
mortality. The disease also brings about with it a change in lifestyle for the young 
diabetics with the need for daily exogenous insulin therapy, blood glucose 
monitoring and dietary changes. Due to the same reasons, diabetes mellitus 
imposes a great drain on the economy. 
 In India, Government health expenditure accounts for just 2% of the 
monetary budget and 0.8% of the Gross Domestic Product (GDP) (World Bank 
Development indicators). The per capita expenditure on health care is only 6.4% of 
the average global figure, while India accounts for 23.5% of the world’s disability- 
adjusted life years lost due to diabetes4. Given the very limited resources available, 
the main thrust of health care provision is on the eradication of communicable 
diseases. There are also services provided by private medical practitioners for 
those who can afford the cost.  
 Shobana et al.5studied the direct cost of diabetes in patients attending 
secondary care facilities in Chennai, in the private sector. The median direct cost 
for patients receiving diabetes care in the private sector was US$107. They have 
 
reported that the median direct cost to the family of an individual with type 1 
diabetes is US$310(range US$45 –1936). The percentages of family income spent 
on diabetes care were 59%, 32%, 18% and 12% in low, middle, upper-middle and 
upper socio economic groups, respectively. Thus, the disease has its effects not 
only on the growth, development and emotional aspects of a child; it also carries 
the risk of long term complications with its associated morbidity and mortality 
with a significant effect on the economy as well. 
Our experience: 
 The Diabetic clinic at the Institute of Child Health and Hospital for Children 
was started in the year 1999 and has about 300 registered patients. The services 
provided at the clinic include: 
a) Monitoring of blood glucose and insulin therapy 
b) Monitoring of glycemic control 
c) Growth monitoring 
d) Monitoring for complications: 
• Injection site assessment for atrophy / hypertrophy / abscess 
• Annual ophthalmologic review 
• Periodic monitoring of urine microalbuminuria for risk of 
diabetic nephropathy. 
• Blood pressure monitoring. 
 
• Evaluation of hands, feet and peripheral pulses for signs of 
neuropathy or peripheral vascular disease. 
• Evaluating for associated autoimmune disorder like thyroiditis 
in suspected cases. 
During review at the Clinic it was often seen that these children reported certain 
infections like furunculosis, candidiasis and urinary tract infections. Literature 
search did not provide much data on the incidence, type and severity of infections 
in children with type 1 diabetes. So, this study was conceived to look in the 
association between infections and type 1 diabetes in children. Infections in 
diabetic children may be an additional risk factor for morbidity and mortality. 
Infections may increase the need for hospitalisation, insulin therapy and hence, 
also increase the health care costs. This study was planned to look into these 
aspects. 
 
 
 
 
 
 
 
  
 
 
 
Immunopathology of 
infections in diabetes 
mellitus 
 
2. IMMUNOPATHOLOGY OF INFECTIONS                                     
IN DIABETES MELLITUS 
 Diabetes Mellitus is a common chronic metabolic disorder affecting both 
children and adults. It is characterized by chronic hyperglycemia with disturbances 
of carbohydrate, protein and fat metabolism resulting from defects in insulin action 
or insulin secretion or both. It can have long-term effects on the various organs of 
the body like the eye, kidneys, heart, peripheral vessels and nerves. 
The disease was first mentioned in the Eber’s papyrus as early as 1500 B.C 
The discovery of insulin by Banting et al. was a significant breakthrough in the 
history of diabetes. They were followed by many such researchers, who have 
helped us to understand this disease better. And hence there has been a shift of 
terms from the older ‘Non insulin dependent diabetes mellitus’ and ‘Insulin 
dependent mellitus’ to the newer ‘type 1 diabetes mellitus’ and ‘type 2 diabetes 
mellitus’. 
Type 1 Diabetes Mellitus: 
 Type 1 Diabetes Mellitus is a T cell mediated autoimmune disease involving 
β cell damage from inflammatory cytokines and auto-aggressive T-lymphocytes. In 
Type 1 DM, there is absolute insulin deficiency leading on to symptomatic 
hyperglycemia and immediate need for exogenous insulin replacement. 
 
 
Epidemiology: 
 Type 1 diabetes mellitus, the most common form of diabetes mellitus 
encountered in childhood, accounts for approximately two thirds of all cases of 
diabetes mellitus in children2. 
 The incidence and prevalence of Type 1 DM varies dramatically around the 
world, with more than 400 fold variation in the incidence in reporting countries2. 
Type 1 DM is uncommon in India, China with an incidence of only 0.1 / 100,0002. 
It is more common in Finland & Sardinia with an incidence of 50 cases per 
100,000 population per year2. The incidence of Type 1 DM is increasing 
throughout the world especially in nations with a previous low incidence of 
autoimmune diabetes. It is predicted that the overall incidence of Type 1 DM will 
be 40% higher in 2010 than in 19973. Also the disease has a younger age of onset 
now than earlier3. 
Complications of Diabetes Mellitus: 
Diabetes Mellitus is a chronic metabolic disorder characterised by both acute 
and chronic complications.  
Acute complications of Diabetes Mellitus: 
These include DKA, hyperglycemia and hypoglycemia, which occur due to 
the imbalance between insulin therapy and dietary intake or exercise. These are 
often encountered in Type 1 DM.  
 
Diabetic Ketoacidosis: 
It is an important complication of childhood diabetes mellitus and the most 
frequent diabetes – related cause of death in children. It is a syndrome 
characterised by hyperglycemia, ketosis and acidemia. Diabetic Ketoacidosis 
(DKA) in diabetes mellitus can be the initial presentation, an acute metabolic 
compensation or the cause of mortality. In established diabetics, it can be 
precipitated by infections, intercurrent illness or by omission of insulin.  
Chronic complications of Diabetes Mellitus: 
 These include retinopathy, cataracts, hypertension, nephropathy, neuropathy, 
coronary artery disease, peripheral vascular disease etc., These occur due to the 
effects of hyperglycemia or insulinopenia on the various tissues and can be 
prevented by proper glycemic control as was established by the Diabetes Control 
and Complications Trial (DCCT) 6. 
 Infections are an important complication of Diabetes Mellitus and they can 
be commonly encountered in children, whereas the other complications may be 
delayed in their presentation till adolescence or early adulthood. 
Associated complications: 
 These include other autoimmune diseases like thyroiditis, Addison’s disease, 
Celiac disease and Multiple Sclerosis3.  
 
 
Infections and Diabetes Mellitus: 
 It has been a time-honoured concept that the incidence of infections is higher 
in persons with diabetes mellitus and that such infections in the diabetic person 
result in complications and death more frequently than would be anticipated in 
otherwise healthy individuals7, 8. 
 Older studies, upon which much of this information is based, focus 
particularly on infections of the urinary tract, respiratory tree and the extremities 
and derive their data from autopsy cases. However, in these studies, the degree to 
which infection at these sites actually contributed to the cause of death is 
frequently not clear, and control groups were typical lacking9.  
 Later studies, while documenting excess mortality among patients with 
diabetes, ascribed it largely to cardiovascular diseases rather than to uncontrolled 
infection10, 11. For example, pneumonia did not cause an increase in mortality rate 
over that in age and sex matched controls10, 11. 
 Though the associations of diabetes with an increased propensity of 
infection has in general, been well recognised, a more critical re-evaluation of this 
association has received more attention lately. Clearly, some infections occur 
almost exclusively in the diabetic population12. Others are more common in the 
diabetic population12. Still others have a different and more aggressive clinical 
course in the diabetic host12.  
 
 The increased frequency and severity of infection in diabetes mellitus have 
been ascribed to the incompletely defined abnormalities in cell-mediated immunity 
and phagocyte function, hyperglycemia and diminished vascularisation. 
Hyperglycemia is proposed to aid the colonisation and growth of a variety of 
organisms like Candida and other fungal species1. 
Diabetes Mellitus and Host Defence: 
Application of immunological techniques in the laboratory has facilitated 
early diagnosis of functional defects in the immune system. The World Health 
Organisation (WHO) has included diabetes in its classification of secondary 
immunodeficiency diseases13. These secondary immunodeficiencies, unlike 
primary immunodeficiencies, can be resolved if their underlying cause (e.g. a 
tumour or steroid treatment) is eliminated. 
            The immune system is a system designed to fight infections while 
maintaining homeostasis, thus avoiding chronic inflammatory processes and 
autoimmune disease. It comprises two arms, one recognising molecular patterns 
and the other recognising variable molecular details. These two components of the 
immune system are called innate and adaptive, respectively. 
            The innate and adaptive immune systems differ both in their mode of 
immune recognition of triggering factors and in their ability to respond to further 
signals. The adaptive response is generated in such a way as to retain memory, the 
 
basis for vaccine design. The innate response on the other hand does not have the 
ability to remember a previous challenge and therefore has no immunological 
memory. There is a close relationship between innate and adaptive immunity, and 
changes in the former could provoke inappropriate responses in the latter. Since 
changes in innate immunity have been reported in type 1 diabetes, it is possible 
that these changes predispose not only to the disease but also to infections14. There 
is no evidence that the immune response to infections is altered in subjects at risk 
of type 1 or type 2 diabetes. The evidence supports the concept that hyperglycemia 
per se or the metabolic abnormality of diabetes is sufficient to explain the impaired 
immune response in patients responding to infections15. 
Polymorphonuclear Cells: 
 Polymorphonuclear (PMN) granulocytes represent the host’s first defence 
against bacterial agents. In diabetic patients these cells show functional alterations 
in chemotaxy and under some circumstances also in phagocytosis15,16. 
Chemotaxy: 
 This process involves the migration of WBCs. PMN cells are attracted to the 
site of infection by various chemotactic substances secreted by microorganisms. In 
addition complement activation and factors induced locally by PMN cells also play 
a role in this process. The energy required for this is supplied by anaerobic 
glycolysis and by HMP shunt.  
 
 Cells from diabetic patients have a reduced chemotaxy especially when the 
diabetes is poorly controlled15. Monocytes in diabetic patients show a decreased 
cellular response to a chemokine, vascular endothelial growth factor α, because of 
a downstream signal transduction defect17. 
Phagocytosis: 
 There are two phases of phagocytosis 1) Adhesion 2) Ingestion of foreign 
particles into intra cytoplasmic vacuoles. The energy required for this process is 
supplied by ATP produced during anaerobic glycolysis. Phagocytosis may be 
impaired in patients with long standing diabetes16,18 and there is evidence for PMN 
functional impairment19, 20. In general terms the metabolic disturbances associated 
with diabetes are probably important in impairing the function of immune effector 
cells.  
Killing Activity: 
 Once phagosome and lysosome fusion has taken place, killing is carried out 
by lysosomal enzymes. This process is dependent on the integration of oxidative 
and non-oxidative metabolism. Killing activity is usually measured by 1) Nitro 
blue tetrazolium test. 2) Chemiluminescence.  Both tests show a decrease in the 
killing activity of PMN granulocytes associated with high blood glucose. Its 
normalization following intensive insulin therapy augments killing activity within 
48 hours21.  
 
Lymphocytes Population and their Functions: 
 Type 1 DM is associated with alterations in some lymphocyte sub 
population. Several studies have reported a reduction in total number of T-
lymphocytes and more specifically the number of CD4 T cells causing a 
subsequent reduction in CD4/CD8 ratio22,23,24. This defect could due to either 
decreased insulin levels or decreased insulin activity or both25. However, 
optimisation of metabolic control is accompanied by normal lymphocyte 
transformation and normalization of levels of T lymphocytes sub populations26.  
Immunoglobulins: 
 Serum Immunoglobulins levels (IgG and IgA) have been reported to be 
reduced diabetic patients compared to normal subjects27,28. However the antibody 
response in the diabetic population for example to pneumococcal polysaccharide is 
normal29. 
Complement: 
 It is only recently that attention has been paid to the possibility that a 
significant reduction in the quantity and functional activity of complement 
components may occur in diabetic patients. Low C4 levels, often associated with 
the possession of the C4A null gene, are present in approximately 25% of the 
patients with type 1 diabetes30 and abnormalities of other components, e.g., C1q 
and C3 have also been documented31.  
 
Table 1: Predisposing factors for infections in diabetes mellitus12. 
Primary Factors 
Granulocyte adherence, chemo taxis and phagocytic dysfunction 
Myeloperoxidase deficiency 
Complement pathway defects 
Cytokine-mediated (e.g. interleukin-1, tumour necrosis factor) 
Secondary Factors 
Ketoacidosis 
Use of intra vascular access lines 
Antibiotic misuse / resistance 
Frequent hospitalisation 
Peripheral vascular disease 
Neuropathy 
Gastro paresis, reflux and aspiration 
Indwelling urinary catheters 
Chronic renal failure and dialysis 
 
 
A number of factors make certain tissues in diabetic patients particularly 
prone to infections. The four most important elements are an underlying 
susceptibility to infections, vascular disease, nerve damage and hyperglycemia14. 
Hyperglycemia may predispose the diabetic patient to bacterial and fungal 
infections. Neuropathy can 1) alter the pressure distributions contributing to 
ulceration and as a result infection of the feet32 and 2) lead to autonomic 
involvement of the bladder with urine retention which predisposes to bacteriuria32. 
Vascular insufficiency and tissue hypoxia allow the growth of anaerobic organisms 
and limit host defense mechanisms14.  
The complex deterioration of both large and small blood vessels in diabetes 
can result in reduced peripheral circulation, relative hypoxia and as a result a 
predisposition to proliferation of anaerobic bacteria33. Furthermore hypoxia can 
modify the oxygen dependent function of PMN granulocytes34. Finally, reduction 
in antibiotic absorption in diabetic patients with microangiopathy might lead to 
persistence of infections14. 
Diabetes Mellitus and Specific Infections: 
Some infections occur almost exclusively in the diabetic population. Others 
are more common in the diabetic population. They are also predisposed to 
infections with specific micro-organisms and at risk of infections from iatrogenic 
causes. 
 
Table 2:Classifications of Infections in Diabetes 
A) Common infections with increased incidence in diabetic patients 
1) Urinary tract infections 
2) Respiratory tract infections 
3) Soft tissue infections 
B) Infections predominantly occurring in diabetic patients 
1) Malignant otitis externa 
2) Rhinocerebral mucormycosis 
3) Necrotizing fasciitis 
4) Fournier’s gangrene 
5) Emphysematous cholecystitis and pyelonephritis 
6) Infections in diabetic foot 
C) Micro-organisms strongly associated with infections in diabetic patients 
1) Candida species 
2) Group B streptococcus 
3) Klebsiella species 
4) Hepatitis C 
D) Infections resulting from Iatrogenic causes 
1) Insulin injection 
2) Dialysis 
 
  Infections of the urinary tract, respiratory tract and soft tissues occur with 
increased frequency in the diabetic population12. 
1. Urinary Tract Infections: 
Urinary tract infection (UTI) is a frequently encountered problem in diabetic 
patients. The probable causes for increased risk of UTI in diabetic patients include: 
      a) Increased use of urinary catheters35 
b) Presence of diabetic autonomic neuropathy, which causes increased 
residual urine volume, vesicoureteric reflux and recurrent upper 
UTIs36, 37 
c) Coexistent vaginitis, cystocoele and rectocoele12. 
Upper urinary tract is more commonly involved in diabetic patient. A poor 
response to therapy may be due to complications, which may include, papillary 
necrosis or perinephric abscess. Emphysematous pyelonephritis is rare, necrotising 
infection of the renal parenchyma and perirenal tissue with gas formation, mostly 
caused by E.coli12. 
2. Respiratory Tract Infections: 
Diabetic population has an increased propensity to develop infections, in 
particular, Tuberculosis and Pulmonary fungal infections (Coccidiomycosis, 
Aspergillosis and Mucormycosis)38. The frequency of occurrence of tuberculosis is 
 
four times more in diabetics than in non – diabetics38. There is a predilection for 
lower lobes and the disease is more aggressive in poorly controlled diabetes38. The 
lungs in patients with diabetes show histopathologic alterations due to 
accumulation of non- enzymatic glycosylation end products (NGEs) of tissue 
proteins in the connective tissue and this manifests as functional abnormalities: 
reduced lung volumes, reduced pulmonary diffusion capacity and elastic recoil38. 
Again, the alteration in chemo tactic, phagocytic and bactericidal activity of PMNs 
predisposes to infections. 
3. Skin and Soft Tissue Infections: 
 Skin is the body’s largest and thinnest organ and is protected from infections 
by virtue of many factors: 
• Intact stratum corneum 
• Dry and acidic microenvironment 
• Antibacterial effects of lipids, free fatty acids and IgA 
• Endogenous micro flora and 
• Mast cells 
Diabetics are more prone to infections of skin and soft tissue due to:  
• PMNL dysfunction 
• Increased rates of skin colonization with Staphylococcus aureus39 
• Insulin therapy 
 
They are especially prone to specific infections like necrotising fasciitis, 
Fournier’s gangrene, Rhinocerebral Mucormycosis, malignant otitis externa etc12. 
Infections of the foot are seen in adults due to neuropathy, peripheral vascular 
disease and hyperglycemia. 
Micro-organisms Strongly Associated with Infections in Diabetes: 
 Certain micro-organisms appear to cause infections in patients with diabetes 
at a disproportionately high rate. A higher incidence of underlying diabetes has 
been noted in patients with Klebsiella infections such as bacteremia, liver abscess, 
thyroid disease and endophthalmitis40-43.  Although an increased incidence of 
Staphylococcal infections has been noted, a careful recent review did not confirm 
the same39.Among enteric pathogens, Campylobacter and Salmonella enteritidis 
have been reported with increased frequency in patients with diabetes44,45.There is 
a strong association of diabetes with chronic Hepatitis C virus (HCV)46. 
 The association of Candidal infection with diabetes has been well 
recognized. Candidiasis in diabetes is generally localized rather than truly invasive 
or disseminated disease12. Intertriginous candidiasis involves moist skin folds of 
inframammary, inguinal and intergluteal areas and webs of fingers and toes in 
obese individuals. Candida paronychia leads to chronic infection of the proximal 
nail fold. Candida vulvovaginitis is common in women with diabetes mellitus47. 
 
Oropharyngeal candidiasis is a well-documented complication of uncontrolled 
diabetes mellitus12. 
Iatrogenic infections: 
 Infection occurring from self-injection of insulin is quite uncommon, despite 
lack of practices like cleaning the skin or vial48. More recently it has been 
documented that it is not only therapeutically effective to administer insulin 
through clothing, but such practice is not associated with an increased incidence of 
infection. However, needle-site abscesses can occur in patients receiving 
subcutaneous insulin infusion (CSII)49. Infection rates in those receiving 
Continuous Ambulatory Peritoneal Dialysis (CAPD) are comparable to those in 
non- diabetic subjects50. 
 
  
 
 
 
Literature Review 
 
3. LITERATURE REVIEW 
 Infections have all along been considered to occur with greater frequency 
and severity in patients with diabetes mellitus51. This was because at the turn of the 
century, many diabetic patients died of overwhelming infections. However, 
subsequently the introduction of insulin dramatically altered the status and today 
non – communicable diseases like cardiovascular diseases are the leading cause of 
death in diabetic patients as was found by Sasaki et al.10 and Kessler II.11 in two 
independent studies on mortality in diabetic patients. So, it is considered that the 
association between infections and diabetes mellitus needs a more critical re- 
evaluation. 
 The earliest studies in diabetes and infection were done in 1920s when 
Greenwood et al52 in 1927 studied 400 cases of diabetes mellitus and found an 
increased frequency of skin infections, notably, furunculosis, erysipelas, and 
carbuncle. Very recently a cohort study compared all patients with diabetes in 
Ontario, Canada, to matched non- diabetic subjects53. The risk ratio of suffering 
from an infectious disease or death caused by an infectious disease in diabetic and 
non diabetic patients showed that risk ratio was up to 1.92(1.79-2.05). Several 
infections occur more frequently in diabetes, especially severe bacterial infections. 
Diabetes therefore appears to increase the risk of developing an infectious disease 
and dying from an infectious disease. 
 
Urinary Tract Infections and Diabetes Mellitus: 
 Urinary tract infections (UTI) are a common problem in diabetes. 
Asymptomatic bacteriuria occurs with a higher frequency in diabetics: a study by 
Geerlings et al54 demonstrated 26% prevalence in diabetic women, compared to 
6% in controls. Studies have failed to demonstrate significant differences in 
epidemiological, clinical and microbiological features of UTI in patients with or 
without diabetes mellitus except for a higher frequency of catheterization and 
difficulty in eradicating infection in the former group55. 
Upper urinary tract involvement may be up to five times more frequent tin 
diabetics than non-diabetics12. Bilateral kidney disease is also more frequent56. 
Complications like pyelonephritis, renal abscess and papillary necrosis are more 
common. Cortical and peri-renal cysts are more frequent in the diabetic population 
and 25% are caused by staphylococcal septicemia. 
E.coli is the most common bacterial pathogen causing urinary infection in 
patients with diabetes, other organisms being Klebsiella pneumoniae and Proteus 
mirabilis12. Pseudomonas aeruginosa should be suspected if there is a history of 
recent instrumentation or hospitalization12. 
In a study by Lye et al.57comparing 287 diabetic patients with both 
community and hospital acquired UTI and 265 patients with UTI no known risk 
factors, it was found that, E.coli was the most common pathogen causing UTI in 
 
diabetic patients but the number was significantly less than in the control group. 
The number of diabetic patients with Klebsiella as community-acquired infection 
was significantly more than in the control group. In nosocomial UTI in the 
diabetics, Klebsiella preponderance was noted. They concluded that patients with 
diabetes had increased susceptibility to Klebsiella as a pathogen in both 
community acquired and nosocomial UTI. 
Respiratory Infections and Diabetes Mellitus: 
 It is unclear whether diabetes constitutes an independent risk factor for an 
increased incidence and severity of common upper and lower respiratory tract 
infections12. In a prospective study on pneumonia in the community by Woodhead 
et al.58, it was found that compared to patients without diabetes, the overall 
incidence of community – acquired pneumonia may not be higher in patients with 
diabetes. In a large meta- analysis of community-acquired pneumonia by Fine MJ 
et al59, the odds ratio for death associated with diabetes was only 1.3(95% 
confidence interval, 1.1- 1.5). However, the incidence of bacteremia, delayed 
resolution and recurrence may indeed be higher. In addition, infection due to 
certain specific organisms clearly occurs with an increased frequency in diabetes. 
These include Staphylococcus aureus, Gram-negative bacteria, Mycobacterium 
tuberculosis and Mucor.Another group of infections associated with increased 
morbidity and mortality, though not an increased frequency include infections by 
 
streptococci, Legionella and Influenza60. These were observed by Koziel et al60. in 
their study on pulmonary complications of diabetes mellitus: pneumonia.  Lipsky 
et al61 observed in Type 2 diabetics that up to 30% of diabetics are nasal carriers of 
Staphylococcus aureus compared to 11% of the healthy individuals. This is a major 
organism in both community-acquired and nosocomial pneumonia. Gram-negative 
organisms are acquired by aspiration, hematogenous spread or contaminated 
equipment. Aspergillus species, Coccidiodes immitis and Cryptococcus 
neoformans can cause primary pneumonia in the diabetic host. 
  Studies by Marrie et al62. on pneumococcal pneumonia and Bouter et al63. 
on ketoacidosis and pneumonia show that patients with diabetes who develop 
pneumococcal pneumonia are at increased risk of bacteremia as well as a higher 
mortality. During epidemics of influenza, there is an increased mortality and an 
increased incidence of bacterial pneumonia and ketoacidosis in diabetics. The 
increased incidence of nasal colonization with Staphylococcus aureus in diabetics, 
combined with reduced pulmonary ciliary clearance in patients with influenza, 
leads to increased incidence of Staphylococcal pneumonia. So, current guidelines 
recommend both influenza and pneumococcal vaccines for all diabetic patients12. 
 
 
 
 
Tuberculosis and Diabetes Mellitus: 
Diabetics have a risk for increased incidence of tuberculosis and have a 
more advanced disease at presentation12. Reider et al64 reviewed the epidemiology 
of tuberculosis in diabetes mellitus based on three large surveys from 1950s and 
suggested that the relative risk of tuberculosis in individuals with diabetes is 2-3.6 
times that in those without diabetes. In a study from Papua New Guinea65, the 
frequency of occurrence of tuberculosis in diabetic patients was found to be 11 
times the expected rate in the general population. There does not seem to be an 
increased prevalence of patients in developed countries14. There is however, 
evidence for increased rate of both tuberculosis in diabetes mellitus patients and 
new diabetes mellitus in tuberculosis patients in Africa66. 
Diabetics have more advanced disease at presentation and also atypical 
presentations of with greater involvement of the lower lobes, cavitation, pleural 
effusion and multilobe involvement12. While M. tuberculosis used to be a major 
cause of mortality in diabetic patients, this is no longer the case in developed 
countries12. Diabetes does not alter the basic guidelines for prophylaxis and 
treatment of tuberculosis, but it is still indication for tuberculosis testing9. 
 
 
Skin and Soft Tissue Infections and Diabetes Mellitus: 
 Diabetic patients have an increased frequency of deep soft tissue infections, 
both bacterial and fungal. 
Bacterial Infections: 
 There is no clear evidence that diabetic patients are more prone to 
Staphylococcal infections than control subjects14. However, Smith JA et al67 
reported in the Lancet that there is evidence for increased nasal carriage of 
Staphylococcus aureus in diabetic patients, especially those treated with insulin. 
Patients with well-controlled diabetes do not have an increased risk for infection 
post operatively14. Cluff et al68 in their study on staphylococcal bacteremia found 
that the mortality in staphylococcal bacteremia and diabetes is higher than in those 
without the disease. 
Fungal Infections:  
Infection with Candida albicans is believed to be more prevalent in the 
diabetic population. In a study of 100 diabetic and 100 control subjects by Alteras 
et al69, only Candida was detected more frequently in the diabetic group (31% Vs 
5%); other fungi including Trichophyton and Epidermophyton were not more 
prevalent in diabetic patients. Chronic paronychia due to Candida was found in 
10% of young diabetic girls as against 3% of normal subjects in a study by Stone et 
al70 . Hyperglycemia aids the colonisation of Candida species. Hill et al71, using a 
 
direct swab technique, found that a level of HbA1C of 12% or greater correlated 
with yeast colonization.  
 Mucormycosis relates to a group of fulminant infections caused by 
Phycomycetes. Infection with these organisms is rare as there is strong innate 
immunity. The increased risk in diabetics is evident only in those who are 
debilitated, for example with diabetic ketoacidosis14. Batra et al72. have reported 
that about 75% of the patients with mucormycosis have diabetes mellitus. In such 
patients, the natural inhibitory activity of the patient’s serum against the 
Phycomycetes is lost but can return with insulin treatment. 
Diabetic Ketoacidosis and Infections: 
 Various studies have been done in adults to find the incidence of Diabetic 
Ketoacidosis (DKA) in new onset and established cases, the most common 
precipitating factor in DKA and to find the cause of mortality in DKA. 
 Infection has been found to be the most common precipitating factor of 
DKA in the various studies done in adults. In many case series in adults in the last 
20 years, infection was the most common precipitating factor in about 28-43%. 
However, insulin omission is considered to be the most frequent cause of DKA in 
children with known diabetes73. 
 A study done by Chiang et al74 to investigate the frequency of viral and 
bacterial infections in children, who have DKA, showed that bacterial infections 
 
were present in only 13% and viral infections in18%. Among the subgroups of 
children with established diabetes, bacterial infections were present in 17% and 
viral infections in 20%. 
Table 3: DKA study – Chiang et al74 
 Bacterial infections Viral Infections 
All DKA  13% 18% 
DKA in Established diabetics 17% 20% 
 
A study was done by Matoo et al75 at Chandigarh among 143 cases of DKA 
in the age group 8-70 years. 33.5% was new onset DKA and infection was the 
most common precipitating factor (30%). Omission of insulin was the cause in 
20%. Mortality rate was 23.7%.   
 
Table 4: Summary of  DKA studies 
Reference 
Episodes 
(n) 
Infection 
(%) 
Poor insulin 
compliance 
(%) 
New onset 
diabetes 
Faisch et al76 152 43 26 NR 
Kitabchi et al77 202 38 28 22 
Krentz et al78 746 28 13 10 
 
Infections and Glycemic Control: 
Some studies have failed to prove a causal relation ship between 
hyperglycemia and infections like the study by Wheat LJ36 published in the 
Diabetes Care in the year 1980. However, some authors like Moutschen et al15 
suggest that hyperglycemia or the metabolic abnormality is sufficient to explain the 
immune response in patients responding to infections. They have reported that 
cells from diabetic patients have reduced chemotaxy, especially when diabetes is 
poorly controlled. Gin H et al21. reported that the bactericidal capacity of the 
Polymorphonuclear leucocytes, which is decreased in the presence of high blood 
glucose, normalizes following intensive insulin regime. So, there is evidence both 
for and against the fact that poor glycemic control predisposes to infections in 
diabetes mellitus. 
 It is also true that infections in diabetic patients may worsen the glycemic 
control. Stress related hyperglycemia causes release of cytokines that affect 
carbohydrate metabolism. IL -1 and TNF increase net glucose flux and oxidation79. 
In addition, stress causes release of counter regulatory hormones and hence, 
hyperglycemia. So, poor glycemic control may impair the immune response and 
cause infections, which in turn may worsen the glycemic status. 
 
 
 
  
 
 
 
 
 
 
Study Justification 
 
4. STUDY JUSTIFICATION 
 
 
Infections occurring in adult diabetics have been extensively studied but 
literature does not provide much data on infections in childhood diabetes, 
especially in India as research data on diabetes in children is scarce. Review of 
literature shows that infections occur more frequently and with more severity in 
diabetic patients. It is also seen that they are predisposed to certain specific 
infections like those of urinary tract and skin. Infections with certain organisms are 
also found to be more common. Infections may be caused by poor glycemic 
control and may further hamper the glucose homeostasis. Infections are also found 
to be the most common precipitating factor in diabetic ketoacidosis, the most 
frequent diabetic related cause of death in children. There is no data available on 
the incidence of Hepatitis B infection and tuberculosis in diabetic children. Hence 
there is an urgent need to study about infections in diabetic children - whether they 
occur in increased frequency and with more severity. There is also a need to study 
the role of infections in precipitating diabetic ketoacidosis in children with diabetes 
mellitus. 
 
  
 
 
 
 
Objectives of the 
Study 
 
 5. OBJECTIVES OF THE STUDY 
 
 
 
1) To identify the incidence of infections in children with Type 1 Diabetes 
Mellitus. 
2) To determine the type and severity of infections. 
3) To evaluate the risk factors causing infections in diabetic children. 
4) To evaluate the role of infections in precipitating diabetic ketoacidosis in 
diabetic children. 
 
 
 
 
 
 
 
 
 
  
 
 
 
Study Methodology 
 
 6. STUDY METHODOLOGY 
 
Study Design: 
 This study was carried out with a Cohort study design. 
Setting: 
The study was conducted at the Institute of Child Health and Hospital for 
Children, Madras Medical College, a Tertiary care Children’s Hospital in Chennai. 
Study Period: 
  It was done during the period of January 2005 – September 2006 
Study Population: 
Children with Diabetes Mellitus attending the Diabetic clinic at the Institute 
of Child Health and Hospital for Children, Chennai (GROUP 1) were enrolled and 
an equal number of age and sex matched children without Diabetes mellitus 
enrolled from the School Health Cell and Immunisation OPD of the Institute of 
Child Health and Hospital for Children, Chennai as the comparison group 
(GROUP 2). 
 
 
 
 
 
Inclusion Criteria: 
For Group 1: Children with Diabetes Mellitus in the age group of 0 – 12 
years and registered at the Diabetic clinic at Institute of Child Health and Hospital 
for Children and on regular follow up and willing to participate in the study. 
For Group 2: Age and Sex matched children free of Diabetes Mellitus and 
willing to participate in the study. 
 
Exclusion criteria: 
• Children with severe PEM (Grade III and Grade IV PEM) 
• Children with malignancies like leukaemia, lymphoma 
• Children on immunosuppressive drugs or steroids for any reason. 
• Children with Renal failure, nephrotic syndrome or any known 
immunodeficiency states, sickle cell anaemia and recurrent 
wheeze. 
 
Sample size: 
 There is no data on infections in diabetic children, especially in comparison 
with normal children. Hence, the sample size was calculated for an expected 20% 
difference in incidence of infections between the two groups and found to be 112 
in each group. 
 
 
Manoeuvre: 
 The study was conducted at the Institute of Child Health and Hospital for 
Children between the period of January 2005 and September 2006. The cases were 
enrolled for the study from the Diabetic clinic at the Institute.  
Though 300 patients are registered with the clinic many patients collect their 
drug (insulin) from a neighbouring government hospital and come only for 
assessment of glycemic control and complications. The others come for a review 
once in every 6-8 weeks. So, it was decided to enrol patients who lived in and 
around Chennai and collected drugs from the clinic and were on a regular follow 
up. Enrolment was done from April 2006 – June 2006. About 170 children who 
were on regular follow up were selected and data regarding age of onset, family 
history of diabetes mellitus, previous hospitalisations and other relevant medical 
history were collected and anthropometry recorded. 
 Of these 170 children, 112 children who satisfied the inclusion and 
exclusion criteria and who were free of infections at the time of enrolment and who 
were willing to participate in the study were registered. Baseline investigations in 
the Group 1 included complete blood count, peripheral smear, blood glucose, urine 
routine, urine culture and sensitivity, Mantoux and chest X ray. These children 
were advised to come to the clinic for a monthly follow up on Fridays and to meet 
 
the principal investigator. The parents were also encouraged to contact the 
principal investigator in case of intercurrent infections or hospitalisations. 
 At the time of monthly follow up, data was collected regarding any 
intercurrent illness – its type and also severity – i.e., whether it required 
hospitalisation or not. The children were thoroughly examined and anthropometric 
measurements were recorded. All infections in the Group 1 were appropriately 
investigated with complete blood count, peripheral smear, urine routine, urine 
culture and sensitivity, radiological investigation, culture of body fluids & 
serological tests. The children were screened for HBsAg after obtaining consent 
from the patients. For the assessment of glycemic control, HbA1C levels were 
evaluated once in every 4 months i.e., at 4, 8 and 12 months into the study. 
Age and sex matched controls satisfying the inclusion and exclusion criteria 
and willing to participate in the study were enrolled within 3 days of registering a 
case, from the School Health Cell and Immunisation OPD of the Institute of Child 
Health and Hospital for Children, Chennai. Data was recorded regarding a family 
history of diabetes mellitus and relevant medical illness in these children. 
Anthropometric measurements were recorded. No baseline investigation was done 
in this group. These children were followed up monthly at the review OP days on 
Saturdays at the General OPD for a period of one year. The patients were 
encouraged to meet the principal investigator in case of intercurrent illness or 
 
hospitalisations. Appropriate investigations were done for these children when they 
developed infections. They were not tested for HBsAg. Mantoux and Chest X ray 
were not done.  HbA1C was also not done in this group, as it is not relevant. 
Both the groups were investigated based on the signs and symptoms of 
infection only. There was no difference in the intensity of the investigations done 
in either group.  
Any documented infection based on clinical and/or lab investigations was 
considered as an outcome measure. List of expected infections included Urinary 
tract infections, Pneumonia, Impetigo, cellulitis, furunculosis and other soft tissue 
infections, Fungal infections of skin and mucosal membranes, Supportive otitis 
media, Tonsillitis, Sinusitis, fever > 5 days without or localising symptoms , etc., 
Simple URI i.e. fever < 5 days duration with or without cough and rhinitis, fever 
without localising focus of infection and acute watery diarrhoea with a few loose 
stools  lasting for less than three days, all of which did not warrant antimicrobial or 
antimalarial therapy were documented but were not considered as an outcome. The 
detailed definitions for infections considered as outcome in this study are as 
follows: 
Urinary Tract Infection: 
 Clinical signs and symptoms of UTI in the form of fever, dysuria, increased 
frequency of urination, lower abdominal pain and hematuria supported by urine 
 
examination showing pyuria with or without urine culture and sensitivity positivity 
was considered as UTI. 
Pneumonia: 
 Features such as fever, cough, breathlessness, chest pain, preceded by 
symptoms of upper respiratory infection with clinical evidence in the form of 
tachypnea, respiratory distress, cyanosis, adventitious breath sounds with increased 
total WBC count in the range of 15 – 40,000 cells/cu .mm with polymorphic or 
lymphocytic predominance and a positive CRP, confirmed by radiological 
evidence of pneumonia in the form of pneumonitis, consolidation, 
bronchopneumonia with or without pleural effusion and empyema. 
Pharyngitis / Tonsillitis: 
Fever, sore throat, headache, change of voice, dysphagia, with congestion of 
the tonsils with exudates, enlarged tender anterior cervical lymph nodes supported 
by increased total WBC count, with polymorphic predominance and a positive 
CRP confirmed by positive throat swab culture. 
Sinusitis: 
Persistent upper respiratory symptoms of fever, cough, including nasal 
discharge, headache, pain over the sinuses for 10 – 14 days or severe respiratory 
symptoms including purulent nasal discharge and a temperature of at least 102° F 
 
for 3 – 4 days, supported by radiological evidence of infection of the sinuses in the 
form of opacification, mucosal thickening or presence of air fluid levels. 
Otitis Media: 
History of fever, ear pain, irritability, ear discharge supported by otoscopic 
evidence of infection in the form of two of the three abnormalities 1. White, yellow 
of amber or blue colour of the tympanic membrane. 2. Opacification of the 
membrane and 3. Decreased or absent mobility. 
Pyogenic Infections of Skin: 
 Including impetigo, abscess, follicullitis, hydradenitis, cellulitis and ecthyma 
were diagnosed based on that clinical examination findings, Gram stain and culture 
positivity of the blister fluid or a moist plaque if present. 
Candidiasis: 
 Clinical evidence of candidal infection as oral thrush and genital 
involvement as itching, pain, dysuria, vulvar erythema, with cheesy  exudates, 
paronychia and onychomycosis with laboratory evidence of candida in the 
scrapings. 
Septicemia: 
 Clinical features suggestive of sepsis supported by evidence of infection in 
the complete blood count and peripheral smear and a positive CRP confirmed by 
non-enteric blood culture positivity.  
 
Any other infection encountered was diagnosed as per the clinical features 
and confirmed by laboratory evidence. The end point for the diagnosis was based 
on laboratory evidence in the form of culture positivity wherever feasible. 
However in certain conditions where lab evidence was not possible always (for e.g. 
Impetigo) definite clinical features were taken as the end point for infection.   
Diabetic Ketoacidosis: 
All the children admitted with diabetic ketoacidosis during the study period 
(January 2005 – June 2006) were evaluated. Detailed history regarding the clinical 
features and duration, compliance of insulin and  features suggestive of infection 
were taken. Clinical examination for assessing the hydration status, circulatory 
status and to identify the focus of infection was done. Baseline investigations 
included complete blood count, blood sugar, blood urea, serum creatinine and 
serum electrolytes, urine routine with ketones, urine culture and sensitivity, non-
enteric culture and chest X ray. Special additional investigations like culture of 
body fluids were done as required.  
All the children in both the groups completed the one-year follow up period. 
There were no deaths in either group. The results are discussed subsequently. 
 
 
 
  
 
 
 
 
Results 
 
7.  RESULTS 
A total of 112 diabetic children were enrolled in the study. The same number 
of age and sex matched children who were not the siblings of the study children 
were identified from the Immunisation OPD and School Health Cell of The 
Institute of Child Health and Hospital for Children, Chennai were enrolled as the 
comparison group. Both the groups of children were followed up for a period of 
one year from the time of enrolment. They were reviewed every month for the 
presence of infections and the details were documented. The data was analysed 
using SPSS software Version 11.0 for Windows. 
 The results of analysis are presented as follows: 
1.Socio - demographic characteristics  
2.Incidence, type and severity of infections 
3. Risk factors for infections in diabetic children 
7.1.Socio- demographic Characteristics: 
These are presented as follows: 
Age and Sex 
Nutritional status  
Family History of diabetes mellitus  
Diabetic age in diabetic children 
 
 
Age and Sex Distribution of the Study Populations 
The age and sex distribution of the study populations is depicted in the following 
table. 
Table 1: Age and Sex Distribution of the Study populations 
Group 1∗ Group 2∗ Age 
(years) Males Females 
Total 
Males Females 
Total 
< 5 6 13 
19 
(16.96%) 
6 13 
19 
(16.96%) 
5-10 23 31 
54 
(48.21%) 
23 31 
54 
(48.21%) 
> 10 15 24 
39 
(34.82%) 
15 24 
39 
(34.82%) 
Total 
44 
(39.28%) 
68 
(60.71%) 
112 
44 
(39.28%) 
68 
(60.71%) 
112 
Group 1 – Diabetic Children 
Group 2 – Non Diabetic children 
 Of the 112 diabetic children enrolled for the study, 54 children (48.21%) 
were in the age group 5 – 10 years. 39 children (34.82%) and 19 children (16.96%) 
were in the age group above ten years and less than five years respectively.  There 
were 44 males and 68 females in Group 1 constituting 39.28% and 60.71% 
respectively. The controls were chosen to be age and sex matched as per the study 
 
design and their age and sex distribution were similar to the diabetic children as 
revealed by the table. 
Nutritional Status: 
The nutritional status of the study populations is presented as weight, height and 
Body Mass Index (BMI)  percentiles . 
Weight for Age Centiles Distribution: 
The following table shows the weight for age centiles of the study groups. 
Table 2: Weight for Age Centiles Distribution of Group 1 and Group 2: 
 
Group 1 Group 2 Weight 
centiles Males Females Total Males Females Total 
< 5 th 5 2 7(6.25%) 9 14 23(20.53%)
5th- 95th 38 66 104(92.85%) 35 54 89(79.46%)
>95th 1 0 1(0.89%) 0 0 0(0%) 
Total  44 68 112 44 68 112 
 
In the diabetic group, the weight of 104 children(92.85%)were in the normal 
range, seven (6.25%) had weight less than the 5 th centile and one(0.89%) had 
weight above the 95th centile. In the non diabetic group, the weight of 89 
children(79.46%)were normal, 23( 20.53%) were less than 5 th centile and none 
above 95th  centile. 
 
 
 
Height for Age Centiles Distribution: 
The following table shows the height for age centiles of the study groups. 
Table 3: Height for Age Centiles Distribution of Group 1 and Group 2 
Group 1 Group 2 Height 
centiles Males Females Total Males Females Total 
< 5 th 4 4 8(7.14%) 9 17 
26(23.21%) 
5th- 95th 39 63 102(91.07%) 35 51 86(76.78%) 
>95th 1 1 2(1.78%) 0 0 0 (0%) 
Total 44 68 112 44 68 112 
 
In the diabetic group, the height of 102 children(91.07%) were in the normal 
range, eight ( 7.14%) had height less than the 5th centile and two( 1.78%) had 
height above the 95th centile. In the non-diabetic group, the height of 86 
children(76.78%) were normal, 26( 23.21%) were less than 5th centile and none 
above 95th centile. 
 
 
 BMI for Age Centiles Distribution: 
The following table shows the BMI  for age centiles of the study groups. 
Table 4: BMI for age centiles distribution of Group 1 and Group 2 
Group 1 Group 2 BMI 
centiles Males Females Total Males Females Total 
Normal  36 61 97(86.6%) 34 48 82(73.21%)
Underweight 8 6 14(12.5%) 8 17 25(22.32%)
Overweight - - - 2 2 4(3.57%) 
Obese 0 1 1(0.89%) 0 1 1(0.89%) 
Total 44 68 112 44 68 112 
 
Of the 112 children in the diabetic group, 97 children(86.6%) were normal, 
14 were underweight(12.5%), none were overweight and one was obese(0.89%). 
Of the 112 non-diabetic children, 82 (73.21%) were normal, 25(22.32%) were 
underweight, four (3.57%)were overweight and one was obese.  
 
 
 
Family History of Diabetes Mellitus: 
The family history of diabetes mellitus in the children with diabetes mellitus 
is depicted below.  
 
Table 5: Family History of Diabetes in Group 1 
Relation Male Female Total 
Mother 0 1 1 
Father 1 4 5 
Siblings 0 1 1 
Other relatives 12 7 19 
Total 13 13 26 
 
A total of 26 children among the diabetic group had a family history of 
diabetes, of whom 13 were males and 13 were females. The table above depicts the 
family history of diabetes in Group 1.  None of the children in Group 2 had a 
positive family history of diabetes. 
 
Diabetic Age: 
This is analysed as diabetic age less than two years and more than two years. 
 
Table 6: Diabetic Age Group: 
Number of children 
Diabetic Age 
Males Females 
Total 
<2 years 18(40.9%) 27(39.7%) 45(40.17%) 
>2 years 26(59.09%) 41(60.29%) 67(59.82%) 
Total 44 68 112 
 
Of the 44 males in Group 1, 18 (40.9%) had a diabetic age less than two 
years, whereas 26 males (59.09%) had a diabetic age more than two years. Among 
the females, 41(60.29%) had a diabetic age more than two years, while 27(39.7%) 
had a diabetic age less than two years. Overall, among the 112 diabetic children, 
45children(40.17%)and 67 children (59.82%)had diabetic age less than two years 
and more than two years respectively. 
 
7.2. Incidence of Infections: 
In this section , the incidence of infections in the study populations is discussed. 
Simple URI, Fever without localizing signs lasting less than five days and acute 
watery diarrhea lasting less than three days were not considered for analysis.             
The following table shows the number of infected children in both the groups. 
 
Table 7: Number of children with infections in Group 1 and Group 2 
Group 1       
(N = 112) 
Group 2       
(N =112) No. of children who had infections n % n % 
p – 
value* 
Total no. of children with infections 56 50.5% 46 41.1% 0.23 
 Skin infections  51 45.5% 23 20.5% 0.000 
Urinary tract infections 7 6.3% 0 - 0.014 
 Respiratory Infections 7 6.3% 22 19.6% 0.005 
*Chi-square test 
Out of the 112 diabetic children, 56 children (50.5%) developed infections 
during the study period. Out of the 112 controls, 46 children (41.1%)developed 
infections during the study period. Analysis by Chi- square test, revealed no 
statistical difference in the total number of infected children between the two 
groups. However, the presence of individual infections showed a significant 
difference between the two groups. 51 children (45.5%) of the 112 diabetic 
 
children, developed bacterial and fungal infections of the skin during the study 
period as against 23 children (20.5%) in the control group. Analysis revealed a 
statistical significance of p –0.0000. 7(6.3%) of the diabetic children developed 
Urinary tract infections whereas none in the control group had the same in the one-
year follow up period. This again was found to be statistically significant. Analysis 
of the total respiratory infections in the groups showed that there were only 7 cases 
(6.3%) among diabetics as against 22 cases (19.6%) in the control group. This also 
had statistical significance, however with respiratory infections being more in the 
Group 2.  
 
 
 
 
 
 
 
 
 
Number and Type of Infections in the Study Populations:  
The table below shows the number and type of infections in both the groups. 
Table 8: Type of Infections in Group 1 and Group 2: 
Infections Group 1 Group 2 
Respiratory Infections:   
Pneumonia 1 1 
Sinusitis 1 2 
Pharyngotonsillitis 2 16 
ASOM 3 3 
Urinary tract infections 8 0 
Skin and soft tissue infections:   
Bacterial Infections 77 21 
Fungal Infections 13 2 
Sepsis 0 0 
TOTAL 107 45 
 
A total of 107 infections were encountered in among the diabetic children during 
the one-year follow up as against only 45 infections in the normal children during 
the same period. Of the 107 infections in Group 1, skin and soft tissue infections 
were the most commonly encountered. A total of 90(84.1%) infections of the skin 
and soft tissue were seen during the study period. Bacterial infections (71.96%) 
were more common than fungal (12.14%) of the skin. In Group 2, only 23 (51.1%) 
 
were infections of the skin and soft tissue. Here again, bacterial infections 
(46.66%) were commoner than fungal (4.44%). A total of eight Urinary tract 
infections (7.4%) were seen in the diabetic group and none in the control group 
(0%) during the one-year follow up. There were 22 (48.88%) infections of the 
respiratory tract in Group 2 as against 7(6.5%) in Group 1. 
This table shows that diabetic children had more number of infections when 
compared to the normal children. Also, infections of the skin and soft tissue and 
urinary tract were more commonly seen in the diabetic children. 
None of the diabetic children tested positive for HBsAg. Though three 
children had Mantoux positivity, none required treatment with Anti tuberculous 
therapy. 
Also, 27 of the 56 infected diabetic children (48.21%) had more than one 
infection during the study period, with one child recording a maximum of 10 
infections. None in the control group had more than one infection during the study 
period. 
 
 
 
 
 
 
Infections of the Skin and Soft Tissue: 
Below is shown, the type of skin infections in both the groups. 
Table 9: Type of Skin infections in Group 1 and Group 2: 
Skin Infections Group 1 Group 2 
Bacterial infections:   
Impetigo 31 (34.4%) 14 (60.86%) 
Cellulitis 10  (11.11%) 2  (8.7%) 
Abscess 18   (20%) 0 (0%) 
Furunculosis 14 (15.56%) 5  (21.73%) 
Nail infections  4    (4.44%) 0   (0%) 
Fungal infections:    
Dermatophytosis 3  (3.33%) 2   (8.7)% 
Candidal Infections 10  (11.11%) 0    (0%) 
Total 90 23 
 
  In Group 1, of the 90 infections of the skin and soft tissue, 77 infections 
(85.5%) were bacterial and 13(14.4%) were fungal whereas in Group 2, of the total 
23 skin infections, 21 infections (91.3%) were bacterial and two were fungal 
(8.69%). Among the diabetic children, the most common bacterial infection was 
impetigo (n= 31, 40.25%), followed by abscess (n=18,23.38%). There were 10 
episodes of cellulitis (13%). Furunculosis constituted 18.18%( n=14) and nail 
infections 5.2%( n=4) of the total bacterial skin infections. Of the 18 abscesses 
encountered, five were at the injection site. Staphylococcus aureus was isolated 
 
from one of the five injection site abscesses (n=1, 20%). and ten of the thirteen 
abscesses at other sites (n=10,76.9%). Totally 11 cultures (61.1%) were positive of 
the 18. The rest of the cultures (38.89%) were sterile. Looking at fungal infections 
in Group 1, Candidal infections were the commonest (n=10,76.92%) and 
Dermatophytosis constituted the rest (n=3,23.07%). 
The commonest bacterial infection in Group 2 was impetigo (n=14,66.67%). 
The number of furunculosis and cellulitis seen were five (23.8%) and two (9.52%) 
respectively. All fungal infections were Dermatophytal infections (n=2,100%). No 
Candidal infection was seen. 
Infections of the Urinary Tract: 
The organisms causing urinary tract infections in Group 1 is shown below. 
There were no urinary tract infections in Group 2 during the study period. 
Table 10: Organisms causing urinary tract infections in Group 1 
Organism Number 
E.coli 4(50%) 
Klebsiella 3(37.5%) 
Pseudomonas aeruginosa 1(12.5%) 
Total  8 
 
Of the eight urinary tract infections in Group 1, four (50%) were caused by 
E.coli, and three by Klebsiella (37.5%). One child admitted with Diabetic 
ketoacidosis had urinary tract infection with Pseudomonas aeruginosa (12.5%).  
 
Severity of Infections: 
Severity of infections was assessed in our study by the need for 
hospitalisation. There were three admissions in Group 1 for infections, which 
included leptospirosis, urinary tract infection and abscess of both the thighs. Of the 
14 children admitted for Diabetic Ketoacidosis, five children had associated 
infections. It could not be assessed if the infections in these children posed an 
independent risk factor for hospitalisation. None in the control group had any 
hospitalisations. 
 
 
7.3  Risk Factor Analysis for Infections in Children with Diabetes Mellitus: 
Risk factor analysis was done for children with diabetes mellitus  based on the 
following: 
1.Socio-demographic factors:  
• Age 
• Sex 
• Diabetic age and  
• Nutritional status (BMI). 
2. Glycemic control (Mean HbA1C)  
3. Presence of Diabetic Ketoacidosis (DKA) 
 
Risk factor analysis was done for incidence of total infections and for 
incidence of specific infections like skin and soft tissue, respiratory tract and 
urinary tract. The correlation between infections and diabetic ketoacidosis was also 
analysed. 
 
 
Analysis of Risk Factors for Total Infections : 
The risk factor analysis for total infections in diabetic children is discussed below. 
Table 11: Analysis of risk factors for total infections 
Total Infections 
Yes No  N % 
n % n % 
p-
value*
Age             
< 5 years 19 17.0 10 52.6 9 47.4 
5 - 10 years 54 48.2 27 50.0 27 50.0 
> 10 years 39 34.8 19 48.7 20 51.3 0.96 
Sex             
Male 44 39.3 21 47.7 23 52.3 
Female 68 60.7 35 51.5 33 48.5 0.85 
Diabetic age             
<=2 years 45 40.2 20 44.4 25 55.6 
> 2 years 67 59.8 36 53.7 31 46.3 0.44 
Nutrition: 
    Normal 
    Under weight 
    Overweight 
    Obese 
97 
14 
- 
1 
86.6 
12.5 
- 
0.9 
49 
6 
- 
1 
50.5 
42.9 
- 
100.0 
48 
8 
- 
- 
49.5 
57.1 
- 
- 
0.52 
*Chi-square test 
The incidence of total infections in the diabetic children were analysed with 
respect to age as age less than 5 years, 5-10years and more than 10 years. Of the 19 
children in the Under 5 group, 10(52.6%) had infections. 27of the 54 children 
(50%) in the age group 5-10 years and 19 of the 39 children (48.7%) of age more 
than 12 years had  infections . Analysis by Chi- square test, showed no statistical 
significance. Of the 44 males with diabetes, 21 (47.7%) had infections and 35 of 
the 68 females (51.5%) had infections. Statistical analysis showed no significant 
 
correlation with sex. There were 45 children with diabetic age less than 2 years, of 
whom 20(44.4%) had infections .36 of the 67 children (53.7%) with diabetic age 
more than 2 years had infections. This again was not statistically significant. Of the 
97 children with normal nutrition, 49 (50.5%) had infections and 48 (49.5%) had 
no infections. Six of the14 underweight children (42.1%) had infections and eight 
(57.1%) did not. The one obese child (100%)had no infection. No statistical 
significance was noted. 
Glycemic Status and Occurrence of Total Infections:  
The influence of glycemic status on the occurrence of total infections is shown 
below. 
Table 12: Mean HbA1C Level and Occurrence of Total Infections 
Occurrence of Total 
Infections  
 
All diabetic 
children Had Infection No infection 
p-
value 
 
Mean 
HbA1C 
 
11.7 ± 3.1 13 ± 2.9 10.5 ± 2.8 0.00+ 
+ Two sample t-test 
Mean HbA1C in the study population was 11.7 ±3.1. It was higher in the infected 
children group, with a mean of 13± 2.9, when compared to the non-infected 
diabetics (10.5±2.8). This was found to be statistically significant when analysed 
by the two-sample test. 
 
Analysis of Risk Factors for Skin Infections: 
The risk factor analysis for skin  infections in diabetic children is discussed below. 
Table 13: Analysis of Risk Factors for Skin Infections: 
Skin Infections 
Yes No  N % 
n % n % 
p-value* 
Age             
< 5 years 19 17.0 10 52.6 9 47.4 
5 - 10 years 54 48.2 25 46.3 29 53.7 
> 10 years 39 34.8 16 41.0 23 59.0 0.70 
Sex             
Male 44 39.3 19 43.2 25 56.8 
Female 68 60.7 32 47.1 36 52.9 0.70 
Diabetic age             
<=2 years 45 40.2 19 42.2 26 57.8 
> 2 years 67 59.8 32 47.8 35 52.2 0.70 
Nutrition: 
    Normal 
    Under weight 
    Overweight 
    Obese 
97 
14 
- 
1 
86.6
12.5
- 
0.9 
44 
6 
- 
1 
45.4 
42.9 
- 
100.0 
53 
8 
- 
- 
54.6 
57.1 
- 
- 0.54 
*Chi-square test 
The number of children with skin infections were analysed age wise as less 
than 5 years, 5- 10 years and more than 10 years.10 of 19children under 5 years, 25 
of 54 children (46.3%) between 5 and10 years and 16 of 39children (41%) above 
10 years had skin infections with no statistical significance. 19 of 44 male diabetics 
 
(43.2%) and 32 of 68(47.1%) female diabetics had skin infections, which again 
failed to show any statistical significance. Diabetic age again, did not seem to 
affect the incidence of skin infections as 19 of 45 (42.2%)children with diabetic 
age <2 years had skin infections as against 32 of 67 (47.8%)children with diabetic 
age >2 years. Of the 97 children with normal nutrition, 44 (45.4%) had skin 
infections whereas 53 (54.6%) did not. Six of the 14 underweight children (42.1%) 
had skin infections and eight (57.1%) did not. The one obese child (100%) was 
infected. No statistical significance was noted.  
Glycemic Status and Skin Infections: 
The influence of glycemic status on the occurrence of skin infections is shown 
below. 
Table 14: Mean HbA1C Level and Skin Infections   
Skin Infections 
 
 
 
All Diabetic 
Children 
 
Had Infection No infection 
p-
value+ 
 
Mean 
HbA1C 
11.7 ± 3.1 
13.1 ± 2.8 
 
 
10.6 ± 2.9 
 
 
0.00 
 
 
+ Two sample t-test 
The glycemic status however did affect the occurrence, with greater HbA1C 
levels of 13.1±2.8 being associated with skin infections. In the non-infected group, 
the mean HbA1C was 10.6±2.9. 
 
Analysis of Risk Factors for Respiratory Infections: 
The risk factor analysis for respiratory infections in diabetic children is discussed 
below. 
Table 15: Analysis of risk factors for Respiratory infections in Group 1: 
Respiratory Infections 
Yes No  N % 
n % n % 
p-
value* 
Age             
< 5 years 19 17.0 1 5.3 18 94.7 
5 - 10 years 54 48.2 4 7.4 50 92.6 
> 10 years 39 34.8 2 5.1 37 94.9 0.89 
Sex       
Male 44 39.3 5 11.4 39 88.6 
Female 68 60.7 2 2.9 66 97.1 0.11 
Diabetic age       
<=2 years 45 40.2 2 4.4 43 95.6 
> 2 years 67 59.8 5 7.5 62 92.5 0.70 
Nutrition: 
    Normal 
    Under weight 
    Overweight 
    Obese 
97 
14 
- 
1 
86.6 
12.5 
- 
0.9 
7 
- 
- 
- 
7.2 
- 
- 
- 
90 
14 
- 
1 
92.8 
100.0 
- 
100.0 0.56 
* Chi-square test 
Of the total 7 children with respiratory infections, one was less than 5 years 
old (5.3%), four were between 5-10 years (7.4%) and one was more than 10 years 
(5.1%). Age, did not seem to affect the incidence of respiratory infections when 
 
analysed statistically. 5 males (11.4%)and two females (2.9%) had respiratory tract 
infections .Sex again, did not have any effect on the incidence of respiratory 
infections. 2 children (4.4%) with diabetic age less than 2 years and 5 children 
(7.5%)with diabetic age more than 2 years had respiratory infections with no 
statistical significance. Of the 97 children with normal nutrition, 7(7.2%) had 
respiratory infections whereas 90 (92.8%) did not. None of the underweight or 
obese children were infected. No statistical significance was noted.  
Glycemic Status and Respiratory Infections: 
The influence of glycemic status on the occurrence of respiratory infections is 
shown below. 
Table 16: Mean HbA1C level and Respiratory infections 
Respiratory Infections 
  
All diabetic 
children 
 
Had  
Infection 
No infection 
p-
value+
Mean 
HbA1C 
 
11.7 ± 3.1 12.7 ± 3.7 11.7 ± 3.1 0.40 
+ Two sample t-test 
Mean HbA1C also showed no difference between the diabetic children with 
respiratory infections (Mean HbA1C 12.7±3.7) and those without (11.7±3.1). 
 
Analysis of Risk Factors for Urinary Tract  Infections: 
The risk factor analysis for urinary tract infections in diabetic children is discussed 
below. 
Table 17: Analysis of Risk Factors for Urinary Tract Infections : 
Urinary Tract Infections 
Yes No  N % 
n % n % 
p-
value+ 
Age       
< 5 years 19 17.0 2 10.5 17 89.5 
5 – 10 years 54 48.2 2 3.7 52 96.3 
> 10 years 39 34.8 3 7.7 36 92.3 
 
 
 
0.52 
Sex       
Male 44 39.3 2 4.5 42 95.5 
Female 68 60.7 5 7.4 63 92.6 0.70 
Diabetic age       
<=2 years 45 40.2 5 11.1 40 88.9 
> 2 years 67 59.8 2 3.0 65 97.0 0.12 
Nutrition 
Normal 
Under weight 
Overweight 
Obese 
97 
14 
- 
1 
86.6 
12.5 
- 
0.9 
7 
- 
- 
- 
7.2 
- 
- 
- 
90 
14 
- 
1 
92.8 
100.0 
- 
100.0 0.56 
* Chi-square test 
  Of the eight diabetic children with urinary tract infections, two (10.5%)were 
in the age group less than five years, two (3.7%) in the age groups 5- 10 years and 
three (7.7%) in the age group more than 10 years. No statistical significance for 
 
age was noted. There were two males (4.5%) and five females (7.4%) with no 
statistical significance for sex. Five of the children had diabetic age less than two 
years (11.1%) and two had a diabetic age more than two years (3%). This was also 
not found to be significant statistically. Of the 97 children with normal nutrition, 
7(7.2%) had urinary tract infections whereas 90 (92.8%) did not. None of the 
underweight or obese children were infected. No statistical significance was noted.   
 
Glycemic Status and Urinary Tract  infections: 
The influence of glycemic status on the occurrence of urinary tract  infections is 
shown below. 
Table 18: Mean HbA1C level and Urinary tract infections 
Urinary Tract Infections 
 All diabetic children Had Infection No infection p-value+ 
 
Mean 
HbA1C 11.7 ± 3.1 
 
10.8 ± 2.9 11.8 ± 3.1 0.40 
+ Two sample t-test 
The mean HbA1C was 10.8 ± 2.9 in the diabetic group with urinary tract 
infections and was 11.8 ± 3.1 in the diabetic group with no urinary tract infections. 
Glycemic status did not show any statistically significant association with urinary 
tract infections in the diabetic group. 
 
Infections and Diabetic Ketoacidosis: 
The correlation between infections and Diabetic Ketoacidosis is presented below.  
 
Table 19: Association between Infections and Diabetic Ketoacidosis (DKA) 
 DKA present No DKA 
Infections present 5 51 
No Infections 9 47 
 
Of the 112 diabetic children enrolled in the study, 14 developed Diabetic 
Ketoacidosis during the study period, of which five were associated with 
infections. Analysis showed no significant correlation between infections and 
Diabetic Ketoacidosis. (p value = 0.25) 
 
Infections and Severity of diabetic ketoacidosis: 
Of the 14 children admitted with diabetic ketoacidosis during the study 
period, five had infections. 
Table 20: Infections and Severity of diabetic ketoacidosis 
Infections 
Yes No  N % 
n % n % 
p-
value 
Severity       
Mild 9 64.3 3 33.3 6 66.7 
Moderate 5 35.7 2 40.0 3 60.0 1.00* 
Shock       
Yes 8 57.1 3 37.5 5 62.5 
No 6 42.9 2 33.3 4 66.7 1.00* 
Insulin infusion 
duration (Hours) 20 ± 18 24 ± 24 17 ± 15 0.61+ 
Subcutaneous 
insulin duration 
(Hours) 68 ± 43 46 ± 36 80 ± 43 0.19+ 
Days of hospital 
stay 6 ± 4 4 ± 2 7 ± 5 0.44+ 
* Chi-square test  + Mann-Whitney U test 
The severity of DKA was assessed as mild, moderate and severe based on 
the pH and mental status as per the table in Nelson’s textbook of pediatrics (17th  
edition , Pg 1954). 
 
SEVERITY OF DKA 
 
 Venous pH Clinical  
Normal 7.35 – 7.45 No change  
Mild DKA 7.25 – 7.35 Fatigued  
Moderate DKA 7.15 – 7.25 Kussmaul’s respiration, 
sleepy, arousable  
Severe  < 7.15 Kussmaul or depressed 
respiration, depressed 
sensorium to coma.  
 
Other factors like shock, duration of insulin infusion, duration of 
subcutaneous insulin administered and duration of hospitalisation was compared 
between the children with infections and diabetic ketoacidosis and children with 
diabetic ketoacidosis only. 
  As is evident from the table, none of the factors achieved any statistical 
significance, implying that the presence of infections did not alter the severity of 
diabetic ketoacidosis. Though the mean duration of hospital stay was higher in the 
non-infected group when compared to the infected group, it also did not achieve 
any statistical significance. Probably, other risk factors like poor compliance may 
need to be assessed to find the cause for this seemingly increased duration of 
hospitalisation in the non-infected group. This aspect, though outside the purview 
of this study, may form the basis for future studies in diabetic ketoacidosis 
 
  
 
 
 
 
 
 
 
 
Summary  of the Study 
 
8. SUMMARY OF THE STUDY 
 At the end of a one-year follow up period, it is seen that the number of 
infections are more common in the diabetic children than in the normal children. 
Though the actual number of infected children in both the group is not very 
different between the groups, it is seen that the number of times a diabetic child got 
infected is more than the number of times a normal child got infected during the 
same one year follow up period, i.e.; whenever a diabetic child got infected it had a 
tendency to have recurrent infections which was not so in the case of normal 
children. It is also seen that infections of the skin and soft tissue and urinary tract 
are more common in the diabetic children than in the normal children whereas 
respiratory tract infections are more common in the normal children. While three 
children in the diabetic group were hospitalized for infections, in addition to five 
children with infections and diabetic ketoacidosis, none of the normal children 
were hospitalized for infections. None of the diabetic children in the study suffered 
from Hepatitis B infection or tuberculosis. 
Analysis of risk factors for infections shows that the incidence of total 
infections is not affected by age, sex, nutritional status or diabetic age, but poor 
glycemic control predisposes to an increased number of total infections in the 
infected children. Similarly, the incidence of skin, respiratory, and urinary tract 
infections is not affected by age, sex, nutritional status or diabetic age. The 
 
incidence of skin infections is affected by the glycemic status, with poor glycemic 
control predisposing to more infections of the skin and soft tissue. However, 
incidence of urinary tract infections and respiratory tract infections is not affected 
by the glycemic status. 
  In our study, no correlation has been found between infections and Diabetic 
ketoacidosis or its severity.  
 
 
 
 
 
 
  
 
 
 
 
 
Discussion 
 
 
 
9.  DISCUSSION 
Comparison with Other Studies and Literature Review: 
Most of the studies on infections in diabetes mellitus have been done only in 
adults with either Type 2 or Type 1 diabetes. There is paucity of data on infections 
in diabetes mellitus in children. Review of the literature shows that, people with 
diabetes mellitus have incompletely defined abnormalities of the cell mediated 
immunity, phagocytic function, hyperglycemia and diminished vascularisation all 
of which leads to an increased incidence and frequency of infections in these 
patients1. In fact, the World health Organisation lists diabetes as a secondary 
immunodeficiency disease13. There is also evidence to support the concept that 
hyperglycemia per se or the metabolic abnormality in diabetes is sufficient to 
explain the impaired immune response in patients responding to infections15. It is 
also true that infections in diabetic patients may worsen the glycemic control12, 79. 
So, poor glycemic control may impair the immune response and cause infections, 
which in turn may worsen the glycemic status, and, hence, these children with poor 
glycemic control have recurrent infections. 
 As observed by Smitherman et al.51 our study also shows that infections 
occur with greater frequency and severity than in non- diabetics. Greenwood et 
al.52 in their study found an increased frequency of skin infections, notably, 
 
furunculosis, erysipelas, and carbuncle. In our study also diabetic patients had 
more number of skin and soft tissue and urinary tract infections. Bacterial 
infections of the skin were more common than fungal. However impetigo was the 
commonest bacterial infection in our study among the diabetic population. 
Abscesses and nail infections were more commonly seen in the diabetic 
population. Staphylococcus aureus was the commonest organism isolated. There is 
no clear evidence for increased incidence of Staphylococcal infections in diabetics, 
though the risk of increased nasal61 and skin colonization39 by the same is noted, 
especially for those on insulin therapy. 
As seen in the study by Alteras et al.69, Candida was more common in the 
diabetics than non –diabetics (11.11%Vs 0%) whereas their study showed a 
difference of 31% Vs 5%. Dermatophytosis was not more common in the diabetics 
than in the non diabetics (3.33% Vs 8.75%) as observed in the study by Alteras as 
well. 
E.coli was the most commonly isolated organism causing urinary tract 
infection in our study (50%) followed by Klebsiella(37.5%).Nirmal Joshi12 says 
that E.coli is the commonest organism causing urinary tract infection. This was 
also observed in the study by Lye et al57 where they noted that that though E.coli 
was the commonest pathogen causing urinary tract infection in diabetics, they had 
a significant risk of acquiring Klebsiella infection both in the community and in the 
 
hospital. Our study also shows that, Klebsiella is the next most common pathogen 
causing urinary tract infection in diabetics. One child admitted with Diabetic 
ketoacidosis grew Pseudomonas aeruginosa, which again could be explained by the 
hospitalisation. 
Respiratory infections were not more commonly seen in the diabetic group 
as compared to the normal children. As seen in the Woodhead study58, the 
incidence of pneumonia is not higher in diabetic children. In our study, no serious 
respiratory infections were encountered as quoted in the studies by Fine et al.59 and 
Koziel et al.60 probably because of seeking health care early and lack of exposure 
to certain organisms said to be associated with increased morbidity and mortality 
in diabetics, such as Legionella and influenza. Also, respiratory infections were 
significantly more common in the normal children with the risk of spread from one 
to another. None of the diabetic children in our study had tuberculosis. This is in 
contrast to the study by Reider et al.64 which suggested that the relative risk of 
tuberculosis in individuals with diabetes is 2-3.6 times that in those without 
diabetes. Again , in a study from Papua New Guinea65, the frequency of occurrence 
of tuberculosis in diabetic patients was found to be 11 times the expected rate in 
the general population. However all these were done on adults with diabetes and 
probably more studies would be needed to find the prevalence of tuberculosis in 
diabetes mellitus in children. Again the incidence of HBsAg was not found to be 
 
increased. Fraser et al.46 only found an association with chronic Hepatitis C virus 
infection and not chronic Hepatitis B virus infection. 
A number of in vitro studies done by Moutschen et al.15 and Gin H et 
al.21have proved the impaired immune response in poorly controlled diabetes. Our 
study has established that poor glycemic control does lead on to infections in 
diabetic children, especially of the skin and soft tissue. 
   No correlation between infections and diabetic ketoacidosis was noted. Poor 
compliance is the most common precipitating factor for diabetic ketoacidosis in 
children as per literature. The study by Chiang et al.74 also shows that children with 
diabetic ketoacidosis are not commonly associated with infections.  
 
  
 
 
 
 
 
 
Conclusion 
 
10.  CONCLUSIONS 
 
9 Infections occur more frequently in diabetic patients and with more severity. 
9 Diabetic children are more prone to infections of the skin and urinary tract 
when compared to normal children. 
9 None of the diabetic children in our study suffered from tuberculosis. 
9 None of the diabetic children in our study had Hepatitis B Virus infection. 
9 Poor glycemic control predisposes to infections in diabetic children, 
especially of the skin and soft tissues. 
9 There is no correlation between infections and diabetic ketoacidosis or its   
severity in children with diabetes. 
Maintaining good glycemic control could prevent infections in children with 
diabetes mellitus. Hence, there is an urgent need to create awareness in children 
with diabetes and their parents regarding maintenance of good glycemic control. 
 
  
 
 
 
 
 
 
 
 
 
Annexure - i    
 
Data Entry Form for Registration of Group 1: 
 
S.no 
Name                                   Age                                    Sex  
Address 
Date of Registration 
Family history of Diabetes mellitus: 
Diabetic age as on registration 
Previous hospitalisations: Y /N   
                                           Diagnosis: 
Other medical illnesses : 
Clinical Examination: 
Height (cm):                                        Weight (kg):                         BMI: 
Baseline Investigations: 
Total count:                        Differential count :             Peripheral smear : 
Urine : Albumin                 Sugar                                 Deposits 
Urine  C/S        : 
Mantoux                           Chest X ray:   
HBsAg        : 
HbA1c   :                          1                                2                                    3 
 
 Data Entry Form for Registration of Group 2: 
 
S.No 
Name  
Age 
Sex 
Address 
Date of Registration 
Family history of Diabetes mellitus: 
Medical History: 
Clinical Examination: 
Height (cm): 
Weight (kg): 
BMI: 
 
 
Follow up Visits – Data entry form for Groups 1 and 2: 
Date:                       S.no:                              Visit number : 
Height (cm):            Weight(kg) :                  BMI : 
Complaints: Nil / Fever/ Cough/ breathlessness/diarrhea/vomiting/ Skin infection/ 
dysuria/ itching over genitals/injection site injection/ ear discharge/convulsions/ 
altered sensorium/ others. 
Duration of illness: 
Examination: HR               RR                      BP           Temp 
CVS                     RS                P/A                    CNS 
ENT                      SKIN 
Severity of illness: treated as op/ip 
Investigations: 
TC                    DC                      PS 
Blood Glucose (Group 1): 
Urine R/E: 
Urine Culture and sensitivity: 
Non Enteric Culture and sensitivity: 
Body Fluids Culture and sensitivity: 
Radiological investigations: X rays                                USG  
Final diagnosis:                                  Duration of Hospitalisation: 
 
Proforma for children with Diabetic Ketoacidosis: 
Complaints: 
Duration  : 
Examination: HR           RR               BP          Temp 
CVS                      RS                    P/A               CNS 
SKIN                       ENT 
Focus of Sepsis: 
Features of DKA: 
 1.Dehydration :  Y/N 
2.Acidotic features: Y/N 
3. Shock :              Y/N 
Predisposing Factors :Infections/ Poor compliance/ none 
Investigations: 
TC             DC              PS 
B.Sugar               S.electrolytes                   B.urea               S.creatinine   
pH : 
Urine R/E  
Urine Culture and sensitivity: 
Non Enteric Culture and sensitivity: 
Chest x- ray :                                      Others : 
 
Duration of insulin infusion (hrs): 
Duration of subcutaneous insulin(hrs): 
Duration of Hospitalisation(days): 
Final diagnosis: 
Outcome:              
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